Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical

25/04/2019 07:00

Apr 25 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2019        Mar 31, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               33.74               33.72           173.00    
                   (+0.1 pct)          (+9.6 pct)       (+3.3 pct)  
  Operating            5.29                5.57            27.30    
                   (-5.0 pct)          (+12.3 pct)      (+3.8 pct)  
  Recurring            5.22                5.42            27.90    
                   (-3.6 pct)          (+11.6 pct)      (+1.9 pct)  
  Net                  3.68                3.82            19.00    
                   (-3.6 pct)          (+10.6 pct)      (+5.4 pct)  
  EPS               46.65 yen           48.39 yen       240.29 yen  
  EPS Diluted                           48.34 yen                   
  Ann Div                               66.00 yen        68.00 yen  
  -Q2 div                               31.00 yen        33.00 yen  
  -Q4 div                               35.00 yen        35.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T